Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
作者： Sang Hoon Song , Sahyun Pak , Sejun Park , Cheryn Song , In Gab Jeong
DOI: 10.1016/J.JURO.2014.02.2568
关键词:
摘要: Purpose: We identified risk factors predicting unfavorable pathological outcomes after radical prostatectomy in patients with low prostate cancer. also evaluated the role of magnetic resonance imaging.Materials and Methods: retrospectively reviewed medical records 1,262 who underwent 12-core biopsy, preoperative imaging at a single center between September 2007 June 2012. A total 382 men cancer by D'Amico criteria were included study. Multivariate logistic regression analysis was used to identify outcomes.Results: Median patient age 65 years median specific antigen 4.6 ng/ml. Gleason sum upgraded 212 (55.5%). In 249 (65.1%) on 3 Tesla T2-weighted diffusion-weighted without dynamic contrast imaging. The lesion anterior pos...
jurology.com 参考文章(30)
Nazareno Suardi, Umberto Capitanio, Felix K. H. Chun, Markus Graefen, Paul Perrotte, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Andreas Erbersdobler, Francesco Montorsi, Pierre I. Karakiewicz, Currently used criteria for active surveillance in men with low-risk prostate cancer Cancer. ,vol. 113, pp. 2068- 2072 ,(2008) , 10.1002/CNCR.23827
Lambros Stamatakis, M. Minhaj Siddiqui, Jeffrey W. Nix, Jennifer Logan, Soroush Rais-Bahrami, Annerleim Walton-Diaz, Anthony N. Hoang, Srinivas Vourganti, Hong Truong, Brian Shuch, Howard L. Parnes, Baris Turkbey, Peter L. Choyke, Bradford J. Wood, Richard M. Simon, Peter A. Pinto, Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer. ,vol. 119, pp. 3359- 3366 ,(2013) , 10.1002/CNCR.28216
Nazareno Suardi, Andrea Gallina, Umberto Capitanio, Andrea Salonia, Giovanni Lughezzani, Massimo Freschi, Alexander Mottrie, Patrizio Rigatti, Francesco Montorsi, Alberto Briganti, Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients† Cancer. ,vol. 118, pp. 973- 980 ,(2012) , 10.1002/CNCR.26234
James Thompson, Nathan Lawrentschuk, Mark Frydenberg, Les Thompson, Phillip Stricker, Usanz, None, The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJUI. ,vol. 112, pp. 6- 20 ,(2013) , 10.1111/BJU.12381
Thomas A. Stamey, Biological determinants of cancer progression in men with prostate cancer. JAMA. ,vol. 281, pp. 1395- 1400 ,(1999) , 10.1001/JAMA.281.15.1395
Simon L. Conti, Marc Dall'Era, Vincent Fradet, Janet E. Cowan, Jeffery Simko, Peter R. Carroll, Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer Journal of Urology. ,vol. 181, pp. 1628- 1634 ,(2009) , 10.1016/J.JURO.2008.11.107
David Margel, Stanley A. Yap, Nathan Lawrentschuk, Laurence Klotz, Masoom Haider, Karen Hersey, Antonio Finelli, Alexandre Zlotta, John Trachtenberg, Neil Fleshner, Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study Journal of Urology. ,vol. 187, pp. 1247- 1252 ,(2012) , 10.1016/J.JURO.2011.11.112
Annette Fenner, Prostate cancer: multiparametric MRI scans could be a useful adjunct for active surveillance in prostate cancer. Nature Reviews Urology. ,vol. 10, pp. 247- 247 ,(2013) , 10.1038/NRUROL.2013.56
Hebert Alberto Vargas, Oguz Akin, Asim Afaq, Debra Goldman, Junting Zheng, Chaya S. Moskowitz, Amita Shukla-Dave, James Eastham, Peter Scardino, Hedvig Hricak, Magnetic Resonance Imaging for Predicting Prostate Biopsy Findings in Patients Considered for Active Surveillance of Clinically Low Risk Prostate Cancer Journal of Urology. ,vol. 188, pp. 1732- 1738 ,(2012) , 10.1016/J.JURO.2012.07.024
Lori E Eichelberger, Michael O Koch, John N Eble, Thomas M Ulbright, Beth E Juliar, Liang Cheng, Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer. Modern Pathology. ,vol. 18, pp. 886- 890 ,(2005) , 10.1038/MODPATHOL.3800405